| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wai Conrad | CEO, Counterpart Health | C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON | /s/ Peter J. Rivas as attorney-in-fact for Conrad Wai | 04 Nov 2025 | 0001971702 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLOV | Class A Common Stock | Tax liability | -$340K | -96.4K | -7.57% | $3.53 | 1.18M | 31 Oct 2025 | Direct | F1 |
| transaction | CLOV | Class A Common Stock | Tax liability | -$98.6K | -27.9K | -2.37% | $3.53 | 1.15M | 31 Oct 2025 | Direct | F2 |
| holding | CLOV | Class A Common Stock | 1.61M | 31 Oct 2025 | By Trust. | F3 |
| Id | Content |
|---|---|
| F1 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein. Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025. |
| F2 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2025. |
| F3 | Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee. |